PureTech Health plc (PRTC)
NASDAQ: PRTC · Real-Time Price · USD
18.05
+0.55 (3.14%)
Aug 15, 2025, 10:06 AM - Market open
PureTech Health Revenue
In the year 2024, PureTech Health had annual revenue of $4.83M with 44.98% growth. PureTech Health had revenue of $4.54M in the half year ending December 31, 2024, a decrease of -47.13%.
Revenue (ttm)
$4.83M
Revenue Growth
+44.98%
P/S Ratio
88.67
Revenue / Employee
$86,214
Employees
56
Market Cap
428.08M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.83M | 1.50M | 44.98% |
Dec 31, 2023 | 3.33M | -12.29M | -78.68% |
Dec 31, 2022 | 15.62M | -1.77M | -10.18% |
Dec 31, 2021 | 17.39M | 5.62M | 47.76% |
Dec 31, 2020 | 11.77M | 1.96M | 20.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
PRTC News
- 1 day ago - PureTech Founded Entity Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint - Business Wire
- 3 days ago - PureTech Announces the Launch of Celea Therapeutics With a Mission to Transform the Treatment of Respiratory Diseases - Business Wire
- 4 weeks ago - PureTech Announces Leadership Transition - Business Wire
- 5 weeks ago - PureTech Announces Board Change - Business Wire
- 2 months ago - PureTech Health: Results of Annual General Meeting - Business Wire
- 3 months ago - PureTech to Present at the Jefferies Global Healthcare Conference - Business Wire
- 3 months ago - PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF) - Business Wire
- 3 months ago - PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference - Business Wire